Only 3 Dividend Kings Passed This Brutal Screen. They Could Pay You Well for Years to Come.

The longer the market stays noisy, the more attractive businesses look. That is especially true when those businesses have raised their dividends for more than 50 consecutive years, a rare consistency in any market. Rarer still are those that also deliver strong payouts, healthy revenue growth, and standout long-term gains. Those are the names I…


Only 3 Dividend Kings Passed This Brutal Screen. They Could Pay You Well for Years to Come.

The longer the market stays noisy, the more attractive businesses look.

That is especially true when those businesses have raised their dividends for more than 50 consecutive years, a rare consistency in any market. Rarer still are those that also deliver strong payouts, healthy revenue growth, and standout long-term gains. Those are the names I wanted to focus on here today: three standout dividend kings.

Usingย Barchartโ€™s Stock Screener, I selected the following filters to get my list:

  • Annual Dividend Yield % (FWD): Left blank so I can sort it later from highest to lowest.

  • 5-Year Percent Change: Greater than 50%. I am looking for stocks with more than 50% of upside over the last 5 years.

  • 5-YR Dividend Growth (%): Above 20%. Companies with โ€œHighโ€ to โ€œVery Highโ€ dividend increases.

  • 5-YR Revenue Growth (%):ย Above 30%. I am looking for companies with โ€œVery Highโ€ revenue in the last 5 years.

  • Current Analyst Rating: โ€œModerateโ€ to โ€œStrong Buyโ€.

  • Number of Analysts: 12 or higher. The more, the better.

  • Dividend Investing Ideas: Dividend Kings.

I ran the screen and got exactly three results, and I’ll cover each, starting with AbbVie, which has the highest forward annual dividend yield.

AbbVie Inc. is a biopharmaceutical company that develops medicines for complex, long-term health conditions across immunology, oncology, neuroscience, and aesthetics. It’s also making progress in oncology, with recent Phase 2 data forย ELAHERE showing encouraging results in platinum-sensitive ovarian cancer.

In its most recentย quarterly financials, the company reported sales rose 10% YOY to $16.6 billion. Net income is also up over 8,300% to $1.8 billion, after bouncing from a net loss from the past year. Revenue is also upย 33.53% over the last 5 years.

Further, AbbVieย pays a $6.92 dividend per year per share, translating to around a 3.3% yield- the highest on this list. It also has a 5-year dividend growth of 40%, while the stock gainedย 87% over the same period.

With that, a consensus among 31 analysts rates the stock a โ€œModerate Buy.โ€ Finally, a high target price suggests there’s as much as 43% potential upside over the next year.

The next Dividend King on my list is Nucor Corp, one of the largest steel producers in North America, supplying steel and steel products used across construction, infrastructure, manufacturing, and energy. That reach remains important asย energy security draws more attention, with Nucor providing steel for projects such as pipelines and other power-related construction.

Source link